Non-alcoholic fatty liver disease (NAFLD)–pathogenesis, classification, and effect on drug metabolizing enzymes and transporters

E Cobbina, F Akhlaghi - Drug metabolism reviews, 2017 - Taylor & Francis
Non-alcoholic fatty liver disease (NAFLD) is a spectrum of liver disorders. It is defined by the
presence of steatosis in more than 5% of hepatocytes with little or no alcohol consumption …

[HTML][HTML] Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation

UM Zanger, M Schwab - Pharmacology & therapeutics, 2013 - Elsevier
Cytochromes P450 (CYP) are a major source of variability in drug pharmacokinetics and
response. Of 57 putatively functional human CYPs only about a dozen enzymes, belonging …

Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation

UM Zanger, M Turpeinen, K Klein… - Analytical and bioanalytical …, 2008 - Springer
We investigated the elimination routes for the 200 drugs that are sold most often by
prescription count in the United States. The majority (78%) of the hepatically cleared drugs …

Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in …

NJ Hewitt, MJ Gómez Lechón, JB Houston… - Drug metabolism …, 2007 - Taylor & Francis
This review brings you up-to-date with the hepatocyte research on: 1) in vitro–in vivo
correlations of metabolism and clearance; 2) CYP enzyme induction, regulation, and cross …

Impact of infectious and inflammatory disease on cytochrome P450–mediated drug metabolism and pharmacokinetics

ET Morgan - Clinical Pharmacology & Therapeutics, 2009 - Wiley Online Library
Infection and inflammation are associated with downregulation of hepatic and extrahepatic
cytochrome P450s as well as other drug‐metabolizing enzymes and transporters. We review …

Human cytochrome P450 enzymes

FP Guengerich - Cytochrome P450: structure, mechanism, and …, 2015 - Springer
Abstract The cytochrome P450 (P450) enzymes first attracted interest because of their
relevance to the metabolism of drugs, steroids, and carcinogens. Collectively, the 57 human …

Distinct effects of inflammation on cytochrome P450 regulation and drug metabolism: lessons from experimental models and a potential role for pharmacogenetics

LM de Jong, W Jiskoot, JJ Swen, ML Manson - Genes, 2020 - mdpi.com
Personalized medicine strives to optimize drug treatment for the individual patient by taking
into account both genetic and non-genetic factors for drug response. Inflammation is one of …

Regulation of drug-metabolizing enzymes and transporters in inflammation

AE Aitken, TA Richardson… - Annu. Rev. Pharmacol …, 2006 - annualreviews.org
▪ Abstract Inflammation and infection have long been known to downregulate the activity and
expression of cytochrome P450 (CYP) enzymes involved in hepatic drug clearance. This …

The role of CYP3A in health and disease

LS Klyushova, ML Perepechaeva, AY Grishanova - Biomedicines, 2022 - mdpi.com
CYP3A is an enzyme subfamily in the cytochrome P450 (CYP) superfamily and includes
isoforms CYP3A4, CYP3A5, CYP3A7, and CYP3A43. CYP3A enzymes are indiscriminate …

The role of cytochromes P450 in infection

E Stavropoulou, GG Pircalabioru… - Frontiers in …, 2018 - frontiersin.org
Cytochromes are expressed in many different tissues of the human body. They are found
mostly in intestinal and hepatic tissues. Cytochromes P450 (CYPs) are enzymes that oxidize …